Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:2203-2207

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaka, Y.
Right arrow Articles by Imaizumi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaka, Y.
Right arrow Articles by Imaizumi, M.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Lacunes
Right arrow PET and SPECT

(Stroke. 2000;31:2203.)
© 2000 American Heart Association, Inc.


Original Contributions

Noninvasive Measurement of Cerebral Blood Flow With 99mTc-Hexamethylpropyleneamine Oxime Single-Photon Emission Computed Tomography and 1-Point Venous Blood Sampling

Yoshinari Isaka, MD; Satoshi Furukawa, MD; Hideki Etani, MD; Etsuko Nakanishi, MD; Yosuke Ooe, MD Masatoshi Imaizumi, MD

From the Department of Internal Medicine, Osaka National Hospital, Osaka, Japan.

Correspondence and reprint requests to Yoshinari Isaka, MD, Department of Internal Medicine, Osaka National Hospital, Hoenzaka, 2-1-14, Chuo-ku, Osaka 5400006, Japan. E-mail yoshisk{at}onh.go.jp

Background and Purpose—The arterial and venous blood concentration of technetium 99m–labeled hexamethylpropyleneamine oxime (99mTc-HMPAO) reaches an equilibration more rapidly than other CBF tracers. We hypothesized that 99mTc radioactivity of a venous sample at equilibrium, which is similar to that of an arterial sample, would allow estimation of the integrated input function for the clinical measurement of CBF by use of single-photon emission CT.

Methods—In 53 patients with stable cerebrovascular disease, the radioactivity of a venous sample 5 minutes after injection of 99mTc-HMPAO was correlated with 5-minute arterial blood radioactivity and the first 5 minutes of the integrated arterial curves of the lipophilic tracer. The measured CBF values were compared with those of xenon 133.

Results—–The radioactivity of 5-minute venous blood was almost equivalent to that of 5-minute arterial blood (r2=0.987; y=0.993x+1.63; P<0.0001). The correlation between the venous blood radioactivity and the integrated arterial lipophilic fraction was excellent (r2=0.935, P<0.0001). A strong correlation was obtained between 99mTc-HMPAO and 133Xe CBF values (r2=0.825, P<0.0001). CBF values were reproducible (coefficient of variation, 8.6%).

Conclusions—-This approach is fast, simple, and an alternative to continuous blood sampling in clinical quantitative 99mTc-HMPAO CBF studies.


Key Words: cerebral blood flow • cerebrovascular disorders • tomography, emission computed